• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定植于碳青霉烯类耐药肠杆菌科(CRE)的细菌特性及其与后续感染的相关性。

Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.

机构信息

Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

BMC Infect Dis. 2021 Jul 2;21(1):638. doi: 10.1186/s12879-021-06315-0.

DOI:10.1186/s12879-021-06315-0
PMID:34215214
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8254368/
Abstract

BACKGROUND

Searching the risk factors for carbapenem-resistant Enterobacteriaceae (CRE) infection is important in clinical practice. In the present study, we aim to investigate bacterial characteristics of colonizing strains and their correlation with subsequent CRE infection.

METHODS

Between May 2018 and January 2019, patients hospitalized in the department of haematology and intensive care unit (ICU) were screened for CRE by rectal swabs and monitored for the outcome of infection. We identified the species and carbapenemase-encoding genes of colonizing strains and performed antimicrobial susceptibility tests and multilocus sequence typing (MLST). Risk factors for subsequent CRE infections were ascertained by univariate and multivariable analysis.

RESULTS

We collected a total of 219 colonizing strains from 153 patients. Klebsiella pneumoniae was the most abundant species, and MLST analysis showed rich diversity. K. pneumoniae carbapenemase (KPC) was predominant in the infection group (72.4%). In the non-infection group, 35.4% of strains were non-carbapenemase-producing CRE (NCP-CRE), and New Delhi metallo-β-lactamase (NDM) was predominant (42.2%). The rate of high-level carbapenem resistance (minimum inhibitory concentration [MIC] ≥ 64 mg/L for meropenem and ertapenem, ≥ 32 mg/L for imipenem) was remarkably higher in the infection group than in the non-infection group (P <  0.001). Univariate analysis showed that K. pneumoniae, high-level carbapenem resistance, CP-CRE and KPC-CRE were infection risk factors after CRE colonization. On multivariable analysis with different carbapenemase dichotomizations, KPC-CRE (adjusted odds ratio [aOR], 4.507; 95% confidence interval [CI], 1.339-15.171; P = 0.015) or imipenem MIC ≥ 32 mg/L (aOR, 9.515; 95% CI, 1.617-55.977; P = 0.013) were respectively identified as independent risk factors for subsequent infection.

CONCLUSIONS

Patients colonized with KPC-CRE or strains with an imipenem MIC ≥ 32 mg/L were at particularly high risk of subsequent CRE infections during their hospital stay.

摘要

背景

在临床实践中,寻找碳青霉烯类耐药肠杆菌科(CRE)感染的危险因素非常重要。本研究旨在调查定植菌的细菌特征及其与随后 CRE 感染的相关性。

方法

2018 年 5 月至 2019 年 1 月,对血液科和重症监护病房(ICU)住院患者进行直肠拭子筛查,以检测 CRE,并监测感染结局。我们鉴定定植菌的种属和碳青霉烯酶编码基因,并进行抗菌药物敏感性试验和多位点序列分型(MLST)。采用单因素和多因素分析确定随后发生 CRE 感染的危险因素。

结果

我们从 153 名患者中共收集了 219 株定植菌。肺炎克雷伯菌是最丰富的种属,MLST 分析显示其多样性丰富。感染组中主要为产 KPC 酶肺炎克雷伯菌(72.4%)。非感染组中,35.4%的菌株为非产碳青霉烯酶 CRE(NCP-CRE),以新德里金属β-内酰胺酶(NDM)为主(42.2%)。感染组的高水平碳青霉烯类耐药率(美罗培南和厄他培南的最低抑菌浓度 [MIC]≥64mg/L,亚胺培南的 MIC≥32mg/L)显著高于非感染组(P<0.001)。单因素分析显示,肺炎克雷伯菌、高水平碳青霉烯类耐药、CP-CRE 和 KPC-CRE 是 CRE 定植后感染的危险因素。在不同碳青霉烯酶二分法的多因素分析中,KPC-CRE(调整优势比 [aOR],4.507;95%置信区间 [CI],1.339-15.171;P=0.015)或亚胺培南 MIC≥32mg/L(aOR,9.515;95%CI,1.617-55.977;P=0.013)分别被确定为随后感染的独立危险因素。

结论

在住院期间,患者定植 KPC-CRE 或亚胺培南 MIC≥32mg/L 的菌株感染 CRE 的风险特别高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18a4/8254368/d88995922933/12879_2021_6315_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18a4/8254368/922f97e5e00b/12879_2021_6315_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18a4/8254368/d88995922933/12879_2021_6315_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18a4/8254368/922f97e5e00b/12879_2021_6315_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18a4/8254368/d88995922933/12879_2021_6315_Fig2_HTML.jpg

相似文献

1
Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.定植于碳青霉烯类耐药肠杆菌科(CRE)的细菌特性及其与后续感染的相关性。
BMC Infect Dis. 2021 Jul 2;21(1):638. doi: 10.1186/s12879-021-06315-0.
2
Molecular characterization of carbapenem-resistant and emergence of tigecycline non-susceptible strains in the Henan province in China: a multicentrer study.中国河南省耐碳青霉烯类和替加环素不敏感菌株的分子特征:一项多中心研究。
J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001325. Epub 2021 Feb 15.
3
Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).碳青霉烯类耐药肠杆菌科的表型和基因型特征:来自中国一项纵向大规模 CRE 研究的数据(2012-2016 年)。
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S196-S205. doi: 10.1093/cid/ciy660.
4
Imipenem/relebactam activity compared to other antimicrobials against non-MBL-producing carbapenem-resistant Enterobacteriaceae from an academic medical center.比较学术医疗中心产非 MBL 型碳青霉烯酶耐药肠杆菌科对其他抗菌药物的亚胺培南/雷巴他定活性。
Pathog Dis. 2019 Jun 1;77(4). doi: 10.1093/femspd/ftz040.
5
In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.2015 年美罗培南/沃诺拉赞监测项目中耐碳青霉烯肠杆菌科细菌的美罗培南/沃诺拉赞体外活性和碳青霉烯耐药机制特征。
Int J Antimicrob Agents. 2018 Aug;52(2):144-150. doi: 10.1016/j.ijantimicag.2018.02.021. Epub 2018 Mar 3.
6
Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai.上海地区门诊儿童中产碳青霉烯酶肠杆菌科的粪便携带情况及分子流行病学研究。
BMC Infect Dis. 2019 Aug 1;19(1):678. doi: 10.1186/s12879-019-4298-3.
7
Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.中国一项多中心研究:碳青霉烯类耐药肠杆菌科引起的复杂性腹腔内感染的危险因素和分子流行病学。
J Infect Dis. 2020 Mar 16;221(Suppl 2):S156-S163. doi: 10.1093/infdis/jiz574.
8
Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.某大学医院 ICU 和 HSCT 病房高危患者中产碳青霉烯酶肠杆菌科直肠定植的流行病学和危险因素。
Antimicrob Resist Infect Control. 2020 Sep 23;9(1):155. doi: 10.1186/s13756-020-00816-4.
9
Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.碳青霉烯类药物暴露前史是产非碳青霉烯酶类碳青霉烯耐药肠杆菌科和产碳青霉烯酶肠杆菌科的危险因素。
Antimicrob Agents Chemother. 2019 Sep 23;63(10). doi: 10.1128/AAC.00845-19. Print 2019 Oct.
10
Epidemiological characteristics of New Delhi Metallo-β-Lactamase-producing Enterobacteriaceae in the Fourth hospital of Hebei Medical University.河北医科大学第四医院产新德里金属β-内酰胺酶肠杆菌科的流行病学特征。
BMC Infect Dis. 2023 May 5;23(1):298. doi: 10.1186/s12879-023-08242-8.

引用本文的文献

1
Antimicrobial and Anti-Biofilm Activity of Dichlorophen-Functionalized Gold Nanoparticles Against Carbapenem-Resistant .二氯酚功能化金纳米颗粒对耐碳青霉烯类细菌的抗菌及抗生物膜活性
Int J Nanomedicine. 2025 Aug 25;20:10255-10277. doi: 10.2147/IJN.S532807. eCollection 2025.
2
Risk Factors and Prognosis of Polymyxin- and Carbapenem-Resistant Enterobacteriaceae Infections: A Propensity-Matched Real-World Study.耐多粘菌素和碳青霉烯类肠杆菌科细菌感染的危险因素及预后:一项倾向匹配的真实世界研究
Microorganisms. 2025 May 29;13(6):1256. doi: 10.3390/microorganisms13061256.
3
Risk Factors Analysis and Prediction Model Establishment for Carbapenem-Resistant Enterobacteriaceae Colonization: A Retrospective Cohort Study.

本文引用的文献

1
Construction of a Risk Prediction Model for Subsequent Bloodstream Infection in Intestinal Carriers of Carbapenem-Resistant Enterobacteriaceae: A Retrospective Study in Hematology Department and Intensive Care Unit.耐碳青霉烯类肠杆菌科细菌肠道携带者后续血流感染风险预测模型的构建:血液科和重症监护病房的回顾性研究
Infect Drug Resist. 2021 Mar 2;14:815-824. doi: 10.2147/IDR.S286401. eCollection 2021.
2
Clinical and Microbiological Characteristics of Community-Onset Carbapenem-Resistant Enterobacteriaceae Isolates.社区获得性耐碳青霉烯类肠杆菌科细菌分离株的临床和微生物学特征
Infect Drug Resist. 2020 Sep 11;13:3131-3143. doi: 10.2147/IDR.S260804. eCollection 2020.
3
耐碳青霉烯类肠杆菌科细菌定植的危险因素分析及预测模型建立:一项回顾性队列研究
Infect Drug Resist. 2024 Oct 28;17:4717-4726. doi: 10.2147/IDR.S485915. eCollection 2024.
4
Correlation between intestinal CRE colonization and consequent systemic infection in hospitalized patients in China.中国住院患者肠道 CRE 定植与随后全身感染的相关性。
Sci Rep. 2024 Oct 29;14(1):26017. doi: 10.1038/s41598-024-76261-9.
5
A Novel Subsp. T1 Strain from Cow's Milk: Homeostatic and Antibacterial Activity against ESBL-Producing .一种来自牛奶的新型亚种T1菌株:对产超广谱β-内酰胺酶菌株的稳态和抗菌活性
Antibiotics (Basel). 2024 Sep 27;13(10):924. doi: 10.3390/antibiotics13100924.
6
Risk factors of Carbapenem-resistant Enterobacterales intestinal colonization for subsequent infections in hematological patients: a retrospective case-control study.血液科患者碳青霉烯类耐药肠杆菌科细菌肠道定植继发感染的危险因素:一项回顾性病例对照研究
Front Microbiol. 2024 Apr 12;15:1355069. doi: 10.3389/fmicb.2024.1355069. eCollection 2024.
7
Typhimurium with Eight Tandem Copies of on a HI2 Plasmid.在HI2质粒上带有八个串联拷贝的鼠伤寒沙门氏菌。
Microorganisms. 2023 Dec 22;12(1):20. doi: 10.3390/microorganisms12010020.
8
An analysis of differences in Carbapenem-resistant Enterobacterales in different regions: a multicenter cross-sectional study.不同地区碳青霉烯类耐药肠杆菌科细菌的差异分析:一项多中心横断面研究。
BMC Infect Dis. 2024 Jan 22;24(1):116. doi: 10.1186/s12879-024-09005-9.
9
Multicenter study on the prevalence of colonization due to carbapenem-resistant strains before and during the first year of COVID-19, Italy 2018-2020.2018-2020 年意大利 COVID-19 爆发前后碳青霉烯类耐药菌株定植流行的多中心研究。
Front Public Health. 2023 Dec 19;11:1270924. doi: 10.3389/fpubh.2023.1270924. eCollection 2023.
10
Epidemiology and clinical characteristics of patients with carbapenem-resistant enterobacterales infections: experience from a large tertiary care center in a developing country.耐碳青霉烯肠杆菌科感染患者的流行病学和临床特征:来自发展中国家一家大型三级保健中心的经验。
BMC Infect Dis. 2023 Oct 2;23(1):644. doi: 10.1186/s12879-023-08643-9.
Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai.
上海地区门诊儿童中产碳青霉烯酶肠杆菌科的粪便携带情况及分子流行病学研究。
BMC Infect Dis. 2019 Aug 1;19(1):678. doi: 10.1186/s12879-019-4298-3.
4
Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017).中国一家大型教学医院血流感染的抗菌药物耐药趋势:一项 20 年监测研究(1998-2017 年)。
Antimicrob Resist Infect Control. 2019 May 28;8:86. doi: 10.1186/s13756-019-0545-z. eCollection 2019.
5
The Likelihood of Developing a Carbapenem-Resistant Infection during a Hospital Stay.住院期间发生碳青霉烯类耐药感染的可能性。
Antimicrob Agents Chemother. 2019 Jul 25;63(8). doi: 10.1128/AAC.00757-19. Print 2019 Aug.
6
Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).碳青霉烯类耐药肠杆菌科的表型和基因型特征:来自中国一项纵向大规模 CRE 研究的数据(2012-2016 年)。
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S196-S205. doi: 10.1093/cid/ciy660.
7
Retrospective Observational Study from a Chinese Network of the Impact of Combination Therapy versus Monotherapy on Mortality from Carbapenem-Resistant Bacteremia.中国网络的回顾性观察研究:联合治疗与单药治疗对耐碳青霉烯类血流感染死亡率的影响。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01511-18. Print 2019 Jan.
8
Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates.从临床分离株中表型检测碳青霉烯酶产生菌。
J Clin Microbiol. 2018 Oct 25;56(11). doi: 10.1128/JCM.01140-18. Print 2018 Nov.
9
Emergence of co-existence of bla with rmtC and qnrB genes in clinical carbapenem-resistant Klebsiella pneumoniae isolates in burning center from southeast of Iran.伊朗东南部烧伤中心临床耐碳青霉烯肺炎克雷伯菌分离株中bla与rmtC和qnrB基因共存情况的出现
Folia Microbiol (Praha). 2019 Jan;64(1):55-62. doi: 10.1007/s12223-018-0630-3. Epub 2018 Jul 12.
10
Variability in contact precautions to control the nosocomial spread of multi-drug resistant organisms in the endemic setting: a multinational cross-sectional survey.在流行地区控制多药耐药菌医院内传播的接触预防措施中的变异性:一项多国横断面调查。
Antimicrob Resist Infect Control. 2018 Jul 9;7:81. doi: 10.1186/s13756-018-0366-5. eCollection 2018.